相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Decreased Susceptibility to Dihydrofolate Reductase Inhibitors Associated With Genetic Polymorphisms in Ugandan Plasmodium falciparum Isolates
Oriana Kreutzfeld et al.
JOURNAL OF INFECTIOUS DISEASES (2022)
Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183
Laura E. de Vries et al.
NATURE COMMUNICATIONS (2022)
Pre-erythrocytic Activity of M5717 in Monotherapy and Combination in Preclinical Plasmodium Infection Models
Diana Fontinha et al.
ACS INFECTIOUS DISEASES (2022)
Susceptibilities of Ugandan Plasmodium falciparum Isolates to Proteasome Inhibitors
Shreeya Garg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda
Patrick K. Tumwebaze et al.
NATURE COMMUNICATIONS (2022)
Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of UCB7362
Martin A. . Lowe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
The Plasmodium falciparum ABC transporter ABCI3 confers parasite strain-dependent pleiotropic antimalarial drug resistance
James M. Murithi et al.
CELL CHEMICAL BIOLOGY (2022)
Chemogenomics identifies acetyl-coenzyme A synthetase as a target for malaria treatment and prevention
Robert L. Summers et al.
CELL CHEMICAL BIOLOGY (2022)
Structural basis of malaria parasite phenylalanine tRNA-synthetase inhibition by bicyclic azetidines
Manmohan Sharma et al.
NATURE COMMUNICATIONS (2021)
Potent Antimalarials with Development Potential Identified by Structure-Guided Computational Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor Series
Michael J. Palmer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study
Aline Uwimana et al.
LANCET INFECTIOUS DISEASES (2021)
Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials
Maelle Duffey et al.
TRENDS IN PARASITOLOGY (2021)
Artemisinin and multidrug-resistant Plasmodium falciparum - a threat for malaria control and elimination
Mehul Dhorda et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2021)
Evidence of Artemisinin-Resistant Malaria in Africa
Betty Balikagala et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Changing Prevalence of Potential Mediators of Aminoquinoline, Antifolate, and Artemisinin Resistance Across Uganda
Victor Asua et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Plasmodium falciparum Resistance to a Lead Benzoxaborole Due to Blocked Compound Activation and Altered Ubiquitination or Sumoylation
Kirthana M. Sindhe et al.
MBIO (2020)
Lead Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor Series for the Treatment of Malaria
Sreekanth Kokkonda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis
Beatriz Baragana et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Increased stress associated with head-out plethysmography testing can exacerbate respiratory effects and lead to mortality in rats
James J. Lynch et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2019)
Antimalarial pantothenamide metabolites target acetyl-coenzyme A biosynthesis in Plasmodium falciparum
Joost Schalkwijk et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
In vitro selection predicts malaria parasite resistance to dihydroorotate dehydrogenase inhibitors in a mouse infection model
Rebecca E. K. Mandt et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Identification and Mechanistic Understanding of Dihydroorotate Dehydrogenase Point Mutations in Plasmodium falciparum that Confer in Vitro Resistance to the Clinical Candidate DSM265
John White et al.
ACS INFECTIOUS DISEASES (2019)
The antimalarial pipeline
Rob Hooft van Huijsduijnen et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
Drug-Resistance and Population Structure of Plasmodium falciparum Across the Democratic Republic of Congo Using High-Throughput Molecular Inversion Probes
Ozkan Aydemir et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study
Alejandro Llanos-Cuentas et al.
LANCET INFECTIOUS DISEASES (2018)
How to tackle antimalarial resistance?
Didier Leroy
EMBO MOLECULAR MEDICINE (2017)
Synthesis of a Bicyclic Azetidine with In Vivo Antimalarial Activity Enabled by Stereospecific, Directed C(sp3)-H Arylation
Micah Maetani et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study
James S. McCarthy et al.
LANCET INFECTIOUS DISEASES (2017)
New developments in anti-malarial target candidate and product profiles
Jeremy N. Burrows et al.
MALARIA JOURNAL (2017)
Plasmepsins IX and X are essential and draggable mediators of malaria parasite egress and invasion
Armiyaw S. Nasamu et al.
SCIENCE (2017)
Discovery of Antimalarial Azetidine-2-carbonitriles That Inhibit P-falciparum Dihydroorotate Dehydrogenase
Micah Maetani et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Esterase mutation is a mechanism of resistance to antimalarial compounds
Eva S. Istvan et al.
NATURE COMMUNICATIONS (2017)
Alkoxycarbonate Ester Prodrugs of Preclinical Drug Candidate ELQ-300 for Prophylaxis and Treatment of Malaria
Lisa Frueh et al.
ACS INFECTIOUS DISEASES (2017)
Production of New Cladosporin Analogues by Reconstitution of the Polyketide Synthases Responsible for the Biosynthesis of this Antimalarial Agent
Rachel V. K. Cochrane et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Antimalarial Benzoxaboroles Target Plasmodium falciparum Leucyl-tRNA Synthetase
Ebere Sonoiki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy
Beatriz Baragana et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study
Chanaki Amaratunga et al.
LANCET INFECTIOUS DISEASES (2016)
Diversity-oriented synthesis yields novel multistage antimalarial inhibitors
Nobutaka Kato et al.
NATURE (2016)
A Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Improved Drug-like Properties for Treatment and Prevention of Malaria
Margaret A. Phillips et al.
ACS INFECTIOUS DISEASES (2016)
Subtle Changes in Endochin-Like Quinolone Structure Alter the Site of Inhibition within the Cytochrome bc1 Complex of Plasmodium falciparum
Allison M. Stickles et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
A novel multiple-stage antimalarial agent that inhibits protein synthesis
Beatriz Baragana et al.
NATURE (2015)
Malaria medicines: a glass half full?
Timothy N. C. Wells et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Antimalarial 4(1H)-pyridones bind to the Qi site of cytochrome bc1
Michael J. Capper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria
Margaret A. Phillips et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate
Shahul P. Hameed et al.
NATURE COMMUNICATIONS (2015)
Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action
Dominic Birth et al.
NATURE COMMUNICATIONS (2014)
Key molecular events during host cell invasion by Apicomplexan pathogens
Pushkar Sharma et al.
CURRENT OPINION IN MICROBIOLOGY (2013)
Kinetic Flux Profiling Elucidates Two Independent Acetyl-CoA Biosynthetic Pathways in Plasmodium falciparum
Simon A. Cobbold et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Quinolone-3-Diarylethers: A New Class of Antimalarial Drug
Aaron Nilsen et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Selective and Specific Inhibition of the Plasmodium falciparum Lysyl-tRNA Synthetase by the Fungal Secondary Metabolite Cladosporin
Dominic Hoepfner et al.
CELL HOST & MICROBE (2012)
The ABCs of multidrug resistance in malaria
Jan B. Koenderink et al.
TRENDS IN PARASITOLOGY (2010)
Subcellular discharge of a serine protease mediates release of invasive malaria parasites from host erythrocytes
Sharon Yeoh et al.
CELL (2007)
Acidification of the malaria parasite's digestive vacuole by a H+-ATPase and a H+-pyrophosphatase
KJ Saliba et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)